A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
Clinical trial NCT06963177 · RECRUITING
Trial details
- NCT number
- NCT06963177
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-26
- Primary completion
- 2028-05-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.